The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Amantadine hydrochloride Renata 100 mg Capsules, hard

Renata Pharmaceuticals (Ireland) LimitedPA22865/005/001

Main Information

Trade NameAmantadine hydrochloride Renata 100 mg Capsules, hard
Dosage FormCapsule, hard
Licence HolderRenata Pharmaceuticals (Ireland) Limited
Licence NumberPA22865/005/001

Group Information

ATC CodeN04BB01 amantadine


License statusAuthorised
Licence Issued25/02/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back